A carregar...
Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden
Background: Societal decision makers increasingly emphasise their need for evidence based economic analyses to make reimbursement decisions. Objective: To analyse the cost utility of adalimumab, on both incremental cost and incremental quality adjusted life years (QALYs), versus traditional disease...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1755554/ https://ncbi.nlm.nih.gov/pubmed/15550533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2004.027565 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|